NEVIRAPINE for Hiv infection: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 3,476 adverse event reports in the FDA FAERS database where NEVIRAPINE was used for Hiv infection.
Most Reported Side Effects for NEVIRAPINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Foetal exposure during pregnancy | 1,337 | 20.1% | 259 | 155 |
| Drug resistance | 862 | 13.0% | 33 | 14 |
| Virologic failure | 813 | 12.2% | 39 | 21 |
| Viral mutation identified | 518 | 7.8% | 2 | 0 |
| Death | 514 | 7.7% | 513 | 22 |
| Exposure during pregnancy | 462 | 7.0% | 31 | 58 |
| Pathogen resistance | 356 | 5.4% | 13 | 10 |
| Treatment failure | 340 | 5.1% | 34 | 2 |
| Lipodystrophy acquired | 288 | 4.3% | 1 | 39 |
| Maternal exposure during pregnancy | 283 | 4.3% | 36 | 83 |
| Premature baby | 251 | 3.8% | 57 | 28 |
| Hiv infection | 185 | 2.8% | 36 | 21 |
| Eyelid ptosis | 179 | 2.7% | 0 | 0 |
| Drug ineffective | 176 | 2.7% | 8 | 12 |
| Mitochondrial toxicity | 174 | 2.6% | 0 | 6 |
Other Indications for NEVIRAPINE
Product used for unknown indication (1,030)
Prophylaxis against hiv infection (828)
Antiretroviral therapy (460)
Foetal exposure during pregnancy (125)
Acquired immunodeficiency syndrome (90)
Hiv test positive (71)
Antiviral treatment (55)
Maternal exposure timing unspecified (48)
Hiv infection cdc category c (44)
Prophylaxis (41)
Other Drugs Used for Hiv infection
EMTRICITABINE\TENOFOVIR DISOPROXIL (27,672)
TENOFOVIR DISOPROXIL (19,662)
EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (15,794)
LAMIVUDINE (8,963)
DOLUTEGRAVIR (7,207)
COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR DISOPROXIL (6,874)
RITONAVIR (6,739)
EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL (5,840)
EFAVIRENZ (5,261)
BICTEGRAVIR\EMTRICITABINE\TENOFOVIR ALAFENAMIDE (4,854)